Overview of Vitiligo Research October - December 2014
- Vitiligo Screening Tool (VISTO) is a simple, cost-effective, self-administered tool to confirm vitiligo.
- Much lower prevalence of vitiligo and later disease onset among Taiwanese population is reported (0.064%).
- Serum BDNF may be linked to repeatedly reported association of vitiligo with psychiatric disorders.
- Unexpectedly, IL-2 and IL- 6 levels hint at different mechanism of pathogenesis of stress-induced vitiligo.
- Analogue of viral DNA can trigger melanocyte death, which hints at possible contribution of viruses to vitiligo onset.
- Simvastatin is showing potency to reverse and prevent vitiligo in an experimental mouse model.
- Topical latanoprost (prostaglandin F2-alpha analogue) can be used (alone or in combination with NB-UVB phototherapy) to induce repigmentation of vitiligo lesions
- Infrequent topical tacrolimus can be used as prophylactics to prevent relapse after successful repigmentation
- Based on results of study in mice, simvastatin emerges as a novel treatment for vitiligo, capable to prevent vitiligo onset and to reverse already manifested disease
- Ethnical difference in vitiligo prevalence and associated comorbidities profiles has been further confirmed.
- Level of reactive oxygen species in erythrocytes emerges as an indicator of vitiligo activity.
- Involvement of regulatory T-cell abnormalities in vitiligo pathogenesis is gaining more support.
This is a review of research results in the vitiligo field which were indexed in the PubMed database (www.ncbi.nlm.nih.gov/pubmed) for the period from October till December 2014. Retrieved records were manually checked for a relevance to and significance for the field of vitiligo research. Fifty one records were found to be relevant and of interest, and were included into this quarterly overview, under the following sections:
- Reviews & Comments
- Disease Management And Clinical Features
- Quality of life (QoL)
- Vitiligo triggers
- Case reports
- Understanding mechanisms of vitiligo pathogenesis
- Genetic studies
- Candidate biomarkers
- Mechanisms of treatments
- Methodological advancements
- Novel treatment modalities
- Clinical studies and trials
I support the petition to designate June 25 as Vitiligo World Day and save millions of people worldwide from social isolation and persecution.
What is coming?
United Nations ECOSOC session
The tenth session of the Conference of States Parties to the Convention on the Rights of Persons with Disabilities (CRPD) will take place from Tuesday 13 to Thursday ...13 June 2017 10:00, UN Plaza, New York
World Vitiligo Day celebration conference in Detroit, USA
U.S. World Vitiligo Day 2017 Theme: "Step Up for Vitiligo: A Call for Truth, Hope and Change!" Reflecting the mission of the “Step Up for Vitiligo” campaign that came...23 June 2017 18:00, Detroit, Michigan, USA
What tests should be done?
No tests are usually necessary to make the diagnosis. The white patches may be seen more easily under Wood's light examination.
How long does it take to treat vitiligo?
Treatment results will vary by person and type of vitiligo. The rule of thumb is that you will need to allow at least 3 to 6 months before you begin to see results fro...
How can I cure vitiligo?
There is no cure for vitiligo, but there are a number of effective treatment options that can be discussed with your GP or dermatologist. The aim of treatment is to st...
Why there is no drug for vitiligo yet?
Despite the dearth of medications available to treat psoriasis - a disease with similar prevalence numbers and impact on quality of life - vitiligo has no known cure o...